2018's Last Important Pharma Partnering Event Brimming With Opportunities


Athens, 27 November 2018: With 3,364 well-targeted and pre-scheduled one-on-one business meetings, euroPLX 68 Athens ended today as the last important pharma partnering event in 2018. An average of 23.7 face-to-face business meetings per registered company in addition to numerous off-session meetings that have been arranged individually makes the year-end euroPLX one of the most productive ones.

The 142 attending companies were represented by more than 200 delegates from 36 countries worldwide including, for the first time, Vietnam.

Again, this autumn euroPLX Conference experienced a peak in registrations right after CPhI which is assumed to be due to many visitors of this large exhibition arranging follow-up meetings to discuss mutual business opportunities at euroPLX.

The forthcoming 69th pharma partnering conference, euroPLX 69 London (UK) will be held on February 25 + 26, 2019 in the conference facilities of the Sofitel London Heathrow and will focus on business opportunities and challenges arising from the presumably extended Brexit transition period. Details: www.europlx.com